{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:21:08Z","timestamp":1793643668101,"version":"4.5.1"},"reference-count":36,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Medicine and Pharmacy Carol Davila"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background: Bloodstream infections (BSIs) caused by multidrug-resistant non-fermenting Gram-negative bacilli, particularly Pseudomonas aeruginosa and Acinetobacter baumannii, represent a growing public health concern, especially in tertiary care settings. This study aimed to describe the epidemiological and antimicrobial resistance trends of P. aeruginosa and A. baumannii isolated from blood cultures over an eight-year period (2017\u20132024) at a tertiary infectious disease hospital in Bucharest, Romania, especially in the context of the disruption caused by the SARS-CoV-2 pandemic. Methods: A retrospective study was conducted on 43,951 blood cultures processed at the National Institute of Infectious Diseases. Species identification and antibiotic susceptibility testing (AST) were performed using VITEK2, MALDI-TOF MS, and supplementary phenotypic methods. AST interpretation followed EUCAST guidelines. Results: Out of all of the positive blood cultures, 112 (3.63%) were P. aeruginosa and 158 (5.12%) A. baumannii. Multidrug-resistance (MDR) was identified in 46% of P. aeruginosa and 90.73% of A. baumannii isolates. Resistance trends varied, with P. aeruginosa showing a decrease in MDR rates post-COVID-19 pandemic and following antimicrobial stewardship implementation. In contrast, A. baumannii displayed persistently high resistance, with carbapenem and aminoglycoside resistance rates reaching 100% by 2024. Colistin resistance, though low overall, increased in the latter years. Conclusions: The findings highlight the dynamic nature of antimicrobial resistance among P. aeruginosa and A. baumannii. Effective infection control and antimicrobial stewardship programs are crucial in curbing the rise of MDR strains, particularly amid healthcare system disruptions such as the COVID-19 pandemic.<\/jats:p>","DOI":"10.3390\/ph18070948","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T10:44:41Z","timestamp":1750761881000},"page":"948","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Trends in Antimicrobial Resistance of Acinetobacter baumannii and Pseudomonas aeruginosa from Bloodstream Infections: An Eight-Year Study in a Romanian Tertiary Hospital"],"prefix":"10.3390","volume":"18","author":[{"given":"Alina Maria","family":"Borcan","sequence":"first","affiliation":[{"name":"Faculty of Medicine, The University of Medicine and Pharmacy \u201cCarol Davila\u201d, 050474 Bucharest, Romania"},{"name":"The National Institute of Infectious Diseases \u201cProf. Dr. Matei Bals\u201d, 021205 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Rotaru","sequence":"additional","affiliation":[{"name":"The National Institute of Infectious Diseases \u201cProf. Dr. Matei Bals\u201d, 021205 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7756-9670","authenticated-orcid":false,"given":"Laura Georgiana","family":"Caravia","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, The University of Medicine and Pharmacy \u201cCarol Davila\u201d, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai-Cezar","family":"Filipescu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, The University of Medicine and Pharmacy \u201cCarol Davila\u201d, 050474 Bucharest, Romania"},{"name":"The National Institute of Infectious Diseases \u201cProf. Dr. Matei Bals\u201d, 021205 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u0103d\u0103lina","family":"Simoiu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, The University of Medicine and Pharmacy \u201cCarol Davila\u201d, 050474 Bucharest, Romania"},{"name":"The National Institute of Infectious Diseases \u201cProf. Dr. Matei Bals\u201d, 021205 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"ref_2","unstructured":"WHO (2024). WHO Bacterial Priority Pathogens List, 2024: Bacterial Pathogens of Public Health Importance to Guide Research, Development and Strategies to Prevent and Control Antimicrobial Resistance, Antimicrobial Resistance Division (AMR) II and RC (IRC); WHO."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"120190","DOI":"10.1016\/j.envres.2024.120190","article-title":"Dairy farm waste: A potential reservoir of diverse antibiotic resistance and virulence genes in aminoglycoside- and beta-lactam-resistant Escherichia coli in Gansu Province, China","volume":"263","author":"Shoaib","year":"2024","journal-title":"Environ. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s12276-021-00569-z","article-title":"Antibiotic Resistome from the One-Health Perspective: Understanding and Controlling Antimicrobial Resistance Transmission","volume":"Volume 53","author":"Kim","year":"2021","journal-title":"Experimental and Molecular Medicine"},{"key":"ref_5","unstructured":"WHO (2024). Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics, World Health Organization."},{"key":"ref_6","first-page":"309","article-title":"Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"9","author":"Wisplinghoff","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.00355-19","article-title":"The microbiology of bloodstream infection: 20-year trends from the SENTRY Antimicrobial Surveillance Program","volume":"63","author":"Diekema","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1128\/JCM.00376-11","article-title":"Nosocomial bloodstream infections in Brazilian hospitals: Analysis of 2563 cases from a prospective nationwide surveillance study","volume":"49","author":"Marra","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1128\/AAC.00207-10","article-title":"Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes","volume":"54","author":"Tam","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/CCM.0b013e3182377906","article-title":"Clinical outcomes of type III Pseudomonas aeruginosa bacteremia","volume":"40","author":"Hattemer","year":"2012","journal-title":"Crit. Care Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bjm.2016.11.004","article-title":"Carbapenem-resistant Pseudomonas aeruginosa: Association with virulence genes and biofilm formation","volume":"48","author":"Dantas","year":"2017","journal-title":"Braz. J. Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijantimicag.2018.03.018","article-title":"Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm","volume":"52","author":"Recio","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/1758-2229.12653","article-title":"Environmental reservoirs for exoS+ and exoU+ strains of Pseudomonas aeruginosa","volume":"10","author":"Rutherford","year":"2018","journal-title":"Environ. Microbiol. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s001340100979","article-title":"Endemicity, molecular diversity and colonisation routes of Pseudomonas aeruginosa in intensive care units","volume":"27","author":"Bertrand","year":"2001","journal-title":"Intensive Care Med."},{"key":"ref_15","unstructured":"(2025, February 05). Antibiotic Resistance Threats in the United States. 2019 Antibiotic Resistance Threats Report. Antimicrobial Resistance, Available online: https:\/\/www.cdc.gov\/antimicrobial-resistance\/data-research\/threats\/index.html."},{"key":"ref_16","unstructured":"(2025, April 11). Antimicrobial Resistance Threats in the United States. 2021\u20132022 Antimicrobial Resistance, Available online: https:\/\/www.cdc.gov\/antimicrobial-resistance\/data-research\/threats\/update-2022.html."},{"key":"ref_17","unstructured":"Gary, P., Deirdre, C., Geraldine, H., Elmer, K., Paul, S., and Gail, W. (2017). Koneman\u2019s Color Atlas and Textbook of Diagnostic Microbiology, Jones & Bartlett Learning. [7th ed.]."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1017\/ice.2018.52","article-title":"Multidrug resistant Acinetobacter baumanii: A 15-year trend analysis","volume":"39","author":"Russell","year":"2018","journal-title":"Infect Control Hosp. Epidemiol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Xu, M., Fu, Y., Kong, H., Chen, X., Chen, Y., Li, L., and Yang, Q. (2018). Bloodstream infections caused by Klebsiella pneumoniae: Prevalence of blaKPC, virulence factors and their impacts on clinical outcome. BMC Infect. Dis., 18.","DOI":"10.1186\/s12879-018-3263-x"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2147\/IDR.S163944","article-title":"Differential characteristics of Acinetobacter baumannii colonization and infection: Risk factors, clinical picture, and mortality","volume":"11","year":"2018","journal-title":"Infect Drug Resist."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jinf.2010.07.002","article-title":"Clinical manifestations, antimicrobial therapy, and prognostic factors of monomicrobial Acinetobacter baumannii complex bacteremia","volume":"61","author":"Lee","year":"2010","journal-title":"J. Infect."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1017\/ice.2020.15","article-title":"Community-acquired in name only: A cluster of carbapenem-resistant Acinetobacter baumannii in a burn intensive care unit and beyond","volume":"41","author":"Shenoy","year":"2020","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ajic.2017.02.005","article-title":"Persistent nasal carriers of Acinetobacter baumannii in long-term-care facilities","volume":"45","author":"Liou","year":"2017","journal-title":"Am. J. Infect. Control."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1128\/AAC.00652-07","article-title":"Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom","volume":"53","author":"Gaze","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1139\/w04-018","article-title":"Assessment of intra-species diversity among strains of Acinetobacter baumannii isolated from sites contaminated with petroleum hydrocarbons","volume":"50","author":"Sarma","year":"2004","journal-title":"Can. J. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ajic.2020.11.012","article-title":"Infection control response to an outbreak of OXA-23 carbapenemase-producing carbapenem-resistant Acinetobacter baumannii in a skilled nursing facility in Utah","volume":"49","author":"Smith","year":"2021","journal-title":"Am. J. Infect. Control."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1586\/eri.13.12","article-title":"Clinical relevance of the ESKAPE pathogens","volume":"11","author":"Pendleton","year":"2013","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ajic.2010.09.005","article-title":"Environmental contamination because of multidrug-resistant Acinetobacter baumannii surrounding colonized or infected patients","volume":"39","author":"Thom","year":"2011","journal-title":"Am. J. Infect. Control."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1086\/667376","article-title":"Assessing the burden of Acinetobacter baumannii in Maryland: A statewide cross-sectional period prevalence survey","volume":"33","author":"Thom","year":"2012","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jmii.2017.02.004","article-title":"Community-acquired bloodstream infections caused by Acinetobacter baumannii: A matched case-control study","volume":"51","author":"Chen","year":"2018","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_31","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (2025, April 02). Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 14.0, 2024. Available online: https:\/\/www.eucast.org\/clinical_breakpoints\/."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.4037\/ajcc2012732","article-title":"Diagnosing ventilator-associated pneumonia in critically ill patients with sepsis","volume":"21","author":"Su","year":"2012","journal-title":"Am. J. Crit. Care"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","article-title":"Antibiotic resistance in Pseudomonas aeruginosa: Mechanisms and alternative therapeutic strategies","volume":"37","author":"Pang","year":"2019","journal-title":"Biotechnol. Adv."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Baudet, A., Regad, M., Gibot, S., Conrath, \u00c9., Lizon, J., Demor\u00e9, B., and Florentin, A. (2024). Pseudomonas aeruginosa Infections in Patients with Severe COVID-19 in Intensive Care Units: A Retrospective Study. Antibiotics, 13.","DOI":"10.3390\/antibiotics13050390"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"105060","DOI":"10.1016\/j.cmicom.2025.105060","article-title":"Risk factors associated with bloodstream infections caused by Acinetobacter baumannii in hospital settings: A systematic review and meta-analysis","volume":"2","author":"Magrini","year":"2025","journal-title":"CMI Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jgar.2025.04.015","article-title":"Impact of COVID-19 on epidemiology and mortality risk factors in patients with carbapenem-resistant Acinetobacter baumannii bloodstream infections in a tertiary care hospital in Thailand","volume":"43","author":"Chotiprasitsakul","year":"2025","journal-title":"J. Glob. Antimicrob. Resist."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/7\/948\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:57:31Z","timestamp":1760032651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/7\/948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":36,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["ph18070948"],"URL":"https:\/\/doi.org\/10.3390\/ph18070948","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]}}}